These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31100066)

  • 1. Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells.
    Inada M; Shindo M; Kobayashi K; Sato A; Yamamoto Y; Akasaki Y; Ichimura K; Tanuma SI
    PLoS One; 2019; 14(5):e0216358. PubMed ID: 31100066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Non-narcotic Opium Alkaloid Papaverine Suppresses Human Glioblastoma Cell Growth.
    Inada M; Sato A; Shindo M; Yamamoto Y; Akasaki Y; Ichimura K; Tanuma SI
    Anticancer Res; 2019 Dec; 39(12):6743-6750. PubMed ID: 31810939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.
    Tamada K; Nakajima S; Ogawa N; Inada M; Shibasaki H; Sato A; Takasawa R; Yoshimori A; Suzuki Y; Watanabe N; Oyama T; Abe H; Inoue S; Abe T; Yokomizo T; Tanuma S
    Biochem Biophys Res Commun; 2019 Apr; 511(3):665-670. PubMed ID: 30826057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
    Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration.
    Bassi R; Giussani P; Anelli V; Colleoni T; Pedrazzi M; Patrone M; Viani P; Sparatore B; Melloni E; Riboni L
    J Neurooncol; 2008 Mar; 87(1):23-33. PubMed ID: 17975708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of RAGE in radiation-induced acquisition of malignant phenotypes in human glioblastoma cells.
    Seki H; Kitabatake K; Tanuma SI; Tsukimoto M
    Biochim Biophys Acta Gen Subj; 2024 Sep; 1868(9):130650. PubMed ID: 38830560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo.
    Zhang J; Zhu JS; Zhou Z; Chen WX; Chen NW
    Oncol Rep; 2012 May; 27(5):1511-9. PubMed ID: 22246223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive activity of the novel RAGE inhibitor, papaverine, in a mouse model of chronic inflammatory pain.
    Yoshizawa K; Takeuchi K; Nakamura T; Ukai S; Takahashi Y; Sato A; Takasawa R; Tanuma SI
    Synapse; 2021 Mar; 75(3):e22188. PubMed ID: 32979223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
    Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ
    Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Nguyen AH; Detty SQ; Agrawal DK
    Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGB1 affects the development of pulmonary arterial hypertension via RAGE.
    Li WJ; Hu K; Yang JP; Xu XY; Li N; Wen ZP; Wang H
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3950-3958. PubMed ID: 28975966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway.
    Zhang Y; You B; Liu X; Chen J; Peng Y; Yuan Z
    Med Sci Monit; 2019 Aug; 25():6462-6473. PubMed ID: 31461437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
    Montaldi AP; Godoy PR; Sakamoto-Hojo ET
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.
    Ge X; Arriazu E; Magdaleno F; Antoine DJ; Dela Cruz R; Theise N; Nieto N
    Hepatology; 2018 Dec; 68(6):2380-2404. PubMed ID: 29774570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility group box 1 facilitates migration of neural stem cells via receptor for advanced glycation end products signaling pathway.
    Xue X; Chen X; Fan W; Wang G; Zhang L; Chen Z; Liu P; Liu M; Zhao J
    Sci Rep; 2018 Mar; 8(1):4513. PubMed ID: 29540727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with 2'-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness.
    Jeong H; Park J; Shim JK; Lee JE; Kim NH; Kim HS; Chang JH; Yook JI; Kang SG
    J Neurooncol; 2019 May; 143(1):69-77. PubMed ID: 30887242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-addictive opium alkaloids selectively induce apoptosis in cancer cells compared to normal cells.
    Afzali M; Ghaeli P; Khanavi M; Parsa M; Montazeri H; Ghahremani MH; Ostad SN
    Daru; 2015 Feb; 23(1):16. PubMed ID: 25890335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells.
    Cheng M; Liu H; Zhang D; Liu Y; Wang C; Liu F; Chen J
    Am J Nephrol; 2015; 41(3):257-66. PubMed ID: 25924590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.